文献速递胃肠外科疝与腹壁外科

腹腔镜食管裂孔疝修补中补片使用的比较

Surgical and clinical outcomes comparison of mesh usage in laparoscopic hiatal hernia repair.
PubMed 文献 · Surg Endosc · 2020-06-16

单中心回顾性研究纳入2004至2016年292例接受补片修补的成人食管裂孔疝患者,比较人组织基质、生物合成补片与猪组织基质三种补片的手术与临床结局。长期随访中生物合成补片组复发率显著低于人组织基质组,三组术后食管症状均显著改善;补片费用是组间费用差异的主要来源。

要点

  • 生物合成补片长期复发率显著低于人组织基质补片。
  • 三种补片修补后食管症状均较术前显著改善。
  • 补片费用是组间总费用差异的主要组成部分。

核心结论

  • 三种补片组手术结局相似,但补片费用存在显著差异。

研究设计与样本

  • 单中心回顾性综述,纳入2004至2016年接受补片修补的成人食管裂孔疝患者292例。
  • 按补片类型分为人组织基质组162例、生物合成补片组83例、猪组织基质组47例。

主要发现

  • 总体复发率为39%,长期随访中生物合成补片组复发率显著低于人组织基质组,分别为17%与31%,p=0.038。
  • 所有组术后食管症状均较术前显著改善,p<0.001。
  • 组间费用差异的65%至70%由补片费用本身造成,人组织基质为1072美元、生物合成补片为548美元、猪组织基质为1295美元。

关键数值与推荐

  • 长期复发率:人组织基质31%、生物合成补片17%、猪组织基质19%,p=0.038。
  • 补片费用:人组织基质1072美元、生物合成补片548美元、猪组织基质1295美元。

临床怎么用

  • 选择补片类型时需综合考虑复发风险与补片费用,以辅助知情决策。

局限性

  • 本研究为单中心回顾性综述,补片类型选择可能受外科医生与医院偏好影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Use of absorbable mesh in hiatal hernia (HH) repair has been shown to decrease recurrence rates. Our aim was to compare the efficiency of three meshes in relation to the surgical outcomes of patients undergoing HH repair. METHODS: A single-institution retrospective review was done for adult patients who underwent HH repair with mesh between 2004 and 2016. Demographics, intra-operative, and cost data were collected. Esophageal symptoms and medication use were assessed pre- and postoperatively. Surgical outcomes were evaluated at 6-, 12-months, and long-term follow-up. Three groups were created based on type of mesh: human tissue matrix (HTM), biosynthetic mesh (BIOS), or porcine tissue matrix (PTM). Comparisons were performed between groups using SPSS v.26.0 and PC SAS v9.4, α = 0.05. RESULTS: 292 patients were included (HTM:N = 162, BIOS:N = 83, PTM:N = 47). Majority were male (60.4%), Caucasian (93.2%), median age, and BMI of 59 years [25-90 years] and 29.19 kg/m2 [18.9-58.0 kg/m2], respectively. 69% had a large HH. Median follow-up time was 27 months [1-166 months]. Overall recurrence rate was 39%, being significantly lower in BIOS at long-term (HTM: 31%, BIOS: 17%, PTM: 19%, p = 0.038). All groups had a significant postoperative improvement of esophageal symptoms, all p < 0.001. 65-70% of the cost difference between the groups was incurred by the cost of mesh alone (HTM: $1072, BIOS: $548, PTM: $1295), with the remainder attributable to the surgery itself. CONCLUSION: While outcomes of the three mesh groups were similar in our data, there was a significant difference in mesh cost. Surgeon and hospital preference still play a role in choosing the type of mesh used; however, knowledge of the individual mesh cost will help surgeons make better informed decisions.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Armijo PR, Krause C, Xu T, et al. Surgical and clinical outcomes comparison of mesh usage in laparoscopic hiatal hernia repair. Surg Endosc. 2020. PMID: 32556757. doi:10.1007/s00464-020-07703-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。